Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-03-05 @ 2:32 PM
Study NCT ID:
NCT00984867
Status:
COMPLETED
Last Update Posted:
2014-06-13
First Post:
2009-09-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dapagliflozin DPPIV Inhibitor add-on Study
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1690C00010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |